<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский иммунологический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16975</article-id><article-id pub-id-type="doi">10.46235/1028-7221-16975-PCC</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Proinflammatory cytokines, chemokine CXCL17 and heat shock proteins in osteoarthritis of the knee joint</article-title><trans-title-group xml:lang="ru"><trans-title>Провоспалительные цитокины, хемокин CXСL17 и белки теплового шока при остеоартрите коленного сустава</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Plekhova</surname><given-names>N. G.</given-names></name><name xml:lang="ru"><surname>Плехова</surname><given-names>Наталья Геннадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Biology), Associate Professor, Head, Interdisciplinary Research Center</p></bio><bio xml:lang="ru"><p>д.б.н., доцент, заведующая Междисциплинарным научно-исследовательским центром</p></bio><email>pl_nat@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kabalyk</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Кабалык</surname><given-names>Максим Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Leading Research Associate, Interdisciplinary Research Center</p></bio><bio xml:lang="ru"><p>к.м.н., доцент, ведущий научный сотрудник Междисциплинарного научно-исследовательского центра</p></bio><email>pl_nat@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Prosekova</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Просекова</surname><given-names>Елена Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Head, Department of Clinical Laboratory Diagnostics, General and Clinical Immunology</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, заведующая кафедрой клинической лабораторной диагностики, общей и клинической иммунологии</p></bio><email>pl_nat@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shumatov</surname><given-names>V. B.</given-names></name><name xml:lang="ru"><surname>Шуматов</surname><given-names>Валентин Борисович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Corresponding Member, Russian Academy of Sciences, Head, Department of Anesthesiology, Resuscitation, Intensive Care and Emergency Medical Care</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, член-корр. РАН, заведующий кафедрой анестезиологии, реанимации, интенсивной терапии и скорой медицинской помощи</p></bio><email>pl_nat@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pacific State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Министерства здравоохранения РФ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-22" publication-format="electronic"><day>22</day><month>12</month><year>2024</year></pub-date><volume>28</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>129</fpage><lpage>134</lpage><history><date date-type="received" iso-8601-date="2024-05-13"><day>13</day><month>05</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-07-31"><day>31</day><month>07</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Plekhova N.G., Kabalyk M.A., Prosekova E.V., Shumatov V.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Плехова Н.Г., Кабалык М.А., Просекова Е.В., Шуматов В.Б.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Plekhova N.G., Kabalyk M.A., Prosekova E.V., Shumatov V.B.</copyright-holder><copyright-holder xml:lang="ru">Плехова Н.Г., Кабалык М.А., Просекова Е.В., Шуматов В.Б.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/16975">https://rusimmun.ru/jour/article/view/16975</self-uri><abstract xml:lang="en"><p>Osteoarthritis (OA), a common multifactorial disease of musculoskeletal system, is one of the leading causes of disability in the population. One of the most important pathogenetic factors of OA is a shift of cytokine profile towards pro-inflammatory state. Their increased levels lead to dysfunction of cartilage tissue cells with its damage. Purpose of the present study was to evaluate diagnostic significance of the most important cytokine and chemokine levels involved in pathogenesis of OA.</p> <p>The study involved 50 patients undergoing inpatient treatment at the “Hospital for War Veterans” (Vladivostok) with an established OA of the knee joints. The following mediators involved in the development of inflammation have been determined: interleukins IL-1â, IL-6, chemokine CXCL17, tumor necrosis factor TNFá and heat shock proteins HSP27, HSP70 in blood serum of patients being analyzed by ELISA test systems. It has been shown that the levels of interleukins IL-1â and IL-6, TNFá and CXCL17 in patients with OA exceeded those for healthy individuals. The levels of cytokines IL- 1â, IL-6, chemokine CXCL17 and TNFá in blood serum of OA patients were 7.4 (6.4-8.9), 33.7 (26.5-68.4); 33.8 (29.8- 61.0) and 6.5 (4.94-8.59) pg/ml, respectively, thus significantly exceeding the values for healthy person s (1.3 (1.2-1.4), 5.8 (4.2-6.3), 24.9 (19, 1-29.9) and 2.7 (2.1-3.1) pg/ml, p &lt; 0.05). In OA patients, the concentration of TNFá had a direct relationship with the chemokine CXCL17 (r = 0.83, p &lt; 0.05). The concentrations of heat shock proteins HSP27, HSP70 and their ratio were significantly lower in patients with OA compared to the control group (respectively: z = -3.06, p = 0.002; z = -4.41, p = 0.00001; z = -2.05, p = 0.04), thus allowing us to suggest the tolerance of chondrocytes to the influence of cytokines. At the same time, the concentration of HSP70 decreased as the disease progressed, while the level of HSP27 did not change significantly. Thus, determining the level of systemic intercellular mediators enables usage of these indexes as potential biochemical markers for predicting severity of the disease and assessing their fundamental role in pathogenesis of knee OA.</p></abstract><trans-abstract xml:lang="ru"><p>Распространенное многофакторное заболевание опорно-двигательного аппарата остеоартрит (ОА) относится к ведущей причине инвалидности населения. Одним из наиболее важных факторов его патогенеза является нарушение баланса цитокинов в сторону провоспалительных, повышение уровня которых приводит к дисфункции клеток хрящевой ткани с ее повреждением.</p> <p>Цель исследования – изучение диагностической значимости показателей содержания наиболее важных цитокинов и хемокинов, участвующих в патогенезе ОА.</p> <p>В исследовании принимало участие 50 пациентов, находящихся на стационарном лечении в КГБУЗ «Госпиталь для ветеранов войн» (г. Владивосток) с установленным диагнозом «ОА коленных суставов». В качестве медиаторов принимающих участие в развитии воспаления, проанализировано содержание методом ELISA в сыворотке крови больных интерлейкинов IL-1â, IL-6, хемокина CXCL17, фактора некроза опухоли TNFá и белков теплового шока HSP27, HSP70.</p> <p>Показано, что уровни интерлейкинов IL-1â и IL-6, TNFá и CXСL17 у больных ОА превышали показатели для здоровых лиц. Показатели содержания цитокинов IL-1â, IL-6, хемокина CXCL17 и TNFá в сыворотке крови больных ОА составили 7,4 (6,4-8,9), 33,7 (26,5-68,4); 33,8 (29,8-61,0) и 6,5 (4,94-8,59) пг/мл, соответственно, что достоверно превышало значения для здоровых лиц (1,3 (1,2- 1,4), 5,8 (4,2-6,3), 24,9 (19,1-29,9) и 2,7 (2,1-3,1) пг/мл, p &lt; 0,05) У больных ОА концентрация TNFá имела прямую связь с показателем хемокина CXCL17 (r = 0,83, p &lt; 0,05). Концентрации белков теплового шока HSP27, HSP70 и их соотношение были достоверно ниже у больных ОА по сравнению с контрольной группой (соответственно: z = -3,06, p = 0,002; z = -4,41, p = 0,00001; z = -2,05, p = 0,04), что позволяет судить о толерантности хондроцитов к влиянию цитокинов. При этом концентрация HSP70 снижалась по мере прогрессирования заболевания, тогда как уровень HSP27 значимо не изменялся. Таким образом, определение уровня системных межклеточных медиаторов позволяет использование этих показателей в качестве потенциальных биохимических маркеров для прогнозирования тяжести заболевания и оценки их фундаментальной роли в патогенезе ОА коленного сустава.</p></trans-abstract><kwd-group xml:lang="en"><kwd>osteoarthritis</kwd><kwd>immunity</kwd><kwd>inflammatory mediators</kwd><kwd>cytokines</kwd><kwd>chemokines</kwd><kwd>heat shock proteins</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>остеоартрит</kwd><kwd>иммунитет</kwd><kwd>медиаторы воспаления</kwd><kwd>цитокины</kwd><kwd>хемокины</kwd><kwd>белки теплового шока</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Министерство здравоохранения Российской Федерации</institution></institution-wrap><institution-wrap><institution xml:lang="en">Ministry of Health of the Russian Federation</institution></institution-wrap></funding-source><award-id>056-00055-24-00</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Кабалык М.А. Биомаркеры и участники ремоделирования субхондральной кости при остеоартрозе // Тихоокеанский медицинский журнал, 2017. Т. 1. С. 36-41. [Kabalyk M.A. Biomarkers of subchondral bone remodeling in osteoarthritis. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal, 2017, Vol. 1, pp. 36-41.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Grässel S., Zaucke F., Madry H. Osteoarthritis: novel molecular mechanisms increase our understanding of the disease pathology. J. Clin. Med., 2021, Vol. 10, no. 9, 1938. doi: 10.3390/jcm10091938.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Giblin S.P., Ranawana S., Hassibi S., Birchenough H.L., Mincham K.T., Snelgrove R.J., Tsuchiya T., Kanegasaki S., Dyer D., Pease J.E. CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling. Front. Immunol., 2023, Vol. 14, 1254697. doi: 10.3389/fimmu.2023.1254697.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gowhari Shabgah A., Jadidi-Niaragh F., Ebrahimzadeh F., Mohammadi H., Askari E., Pahlavani N., Malekahmadi M., Nik M.E., Navashenaq J.G. A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation. Cell. Biol. Int., 2022, Vol. 46, no 10, pp. 1557-1570.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Goekoop R.J., Kloppenburg M., Kroon H.M., Frölich M., Huizinga T.W., Westendorp R.G., Gussekloo J. Low innate production of interleukin-1beta and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthritis Cartilage, 2010, Vol. 18, no 7, pp. 942-947.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ishimoto R., Mutsuzaki H., Shimizu Y., Yoshikawa K., Koseki K., Takeuchi R., Matsumoto S., Hada Y. Association between obesity and short-term patient-reported outcomes following total knee arthroplasty: a retrospective cohort study in Japan. J. Clin. Med., 2024, Vol. 13, no. 5, 1291. doi: 10.3390/jcm13051291.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kaufman J., Caric D., Vukojevic K. Expression pattern of Syndecan-1 and HSP-70 in hip tissue of patients with osteoarthritis. J. Orthop., 2019, Vol. 17, pp. 134-138.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol., 2011, Vol. 7, no 1, pp. 33-42.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Liao Y., Ren Y., Luo X., Mirando A.J., Long J.T., Leinroth A., Ji R.R., Hilton M.J. Interleukin-6 signaling mediates cartilage degradation and pain in posttraumatic osteoarthritis in a sex-specific manner. Sci. Signal., 2022, Vol. 15, no. 744, eabn7082. doi: 10.1126/scisignal.abn7082.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Molnar V., Matišić V., Kodvanj I., Bjelica R., Jeleč Ž., Hudetz D., Rod E., Čukelj F., Vrdoljak T., Vidović D., Starešinić M., Sabalić S., Dobričić B., Petrović T., Antičević D., Borić I., Košir R., Zmrzljak U.P., Primorac D. Cytokines and chemokines involved in osteoarthritis pathogenesis. Int. J. Mol. Sci., 2021, Vol. 22, no. 17, 9208. doi: 10.3390/ijms22179208.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ngarmukos S., Scaramuzza S., Theerawattanapong N., Tanavalee A., Honsawek S. Circulating and synovial fluid Heat Shock Protein 70 are correlated with severity in knee osteoarthritis. Cartilage, 2020, Vol. 11, no. 3, pp. 323-328.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Tan S., Fang W., Vangsness C.T. Jr., Han B. Influence of cellular microenvironment on human articular chondrocyte cell signaling. Cartilage, 2021, Vol. 13, no. 2_suppl, pp. 935S-946S.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Teunis T., Beekhuizen M., Van Osch G.V., Schuurman A.H., Creemers L.B., van Minnen L.P. Soluble mediators in posttraumatic wrist and primary knee osteoarthritis. Arch. Bone Jt Surg., 2014, Vol. 2, no. 3, pp. 146-150.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Vangness C.T., BurkeW.S., NarvyW.S., MacPhee R.D., Fedenko A.N. Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis – A pilot study. Bull. NYU Hosp. Jt Dis., 2011, Vol. 69, pp. 122-127.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Zhang J., Li K., Qiu X. Exploring causal correlations between inflammatory cytokines and knee osteoarthritis: a two-sample Mendelian randomization. Front. Immunol., 2024, Vol. 18, no. 15, 1362012. doi: 10.3389/fimmu.2024.1362012.</mixed-citation></ref></ref-list></back></article>
